Esteu veient aquestes cites basades en navegacions anteriors relacionades amb sectors com
Nom | Net 7 dies | 1 mes net | 3 mes net | 6 mes net | Net 1 any |
---|---|---|---|---|---|
4basebio | £0 | £28,920 | £41,811 | £41,811 | £41,811 |
4D Pharma | n / a | n / a | n / a | n / a | n / a |
Abcam | n / a | n / a | n / a | n / a | n / a |
Abzena | n / a | n / a | n / a | n / a | n / a |
Agronomia Limitada | £0 | £0 | £49,400 | £49,400 | £195,475 |
Al·lergoteràpia | £0 | £0 | £12,000 | £27,512,000 | £27,512,000 |
Alliance Pharma | n / a | n / a | n / a | n / a | n / a |
Grup de cura dels animals | £0 | £0 | £0 | £2,098,245 | £1,737,199 |
Anpari | £0 | £5,190 | £5,190 | £210,512 | £210,806 |
Grup Aptamer | £0 | £0 | £0 | £79,331 | £79,331 |
Aqua Bounty Technologies Inc. (Reg S) | n / a | n / a | n / a | n / a | n / a |
Arecor Therapeutics | n / a | n / a | n / a | n / a | n / a |
Argent Biopharma Limited NPV (DI) | £0 | £0 | £0 | £0 | £1,096,971 |
AstraZeneca | £0 | £0 | £0 | £2,531,067 | £2,533,425 |
Grup Avacta | £0 | £0 | £0 | £0 | - 305,350 lliures esterlines |
Participacions de referència | n / a | n / a | n / a | n / a | n / a |
Beximco Pharmaceuticals Ltd. GDR (Reg S) | n / a | n / a | n / a | n / a | n / a |
Biodexa Pharmaceuticals | n / a | n / a | n / a | n / a | n / a |
Biofrontera AG (DI) | n / a | n / a | n / a | n / a | n / a |
Bioventix | £0 | £0 | £0 | £11,074 | £11,575 |
BiVictriX Therapeutics | £0 | £0 | £0 | £0 | £0 |
BTG | n / a | n / a | n / a | n / a | n / a |
C4X Discovery Holdings | n / a | n / a | n / a | n / a | n / a |
Grup de marques Chill | n / a | n / a | n / a | n / a | n / a |
Cizzle Biotechnology Holdings | n / a | n / a | n / a | n / a | n / a |
Cyprotex | n / a | n / a | n / a | n / a | n / a |
Dechra Pharmaceuticals | n / a | n / a | n / a | n / a | n / a |
Deepverge Plc | n / a | n / a | n / a | n / a | n / a |
Destiny Pharma | £0 | £0 | £0 | £0 | £3,100,000 |
Grup Diürn | n / a | n / a | n / a | n / a | n / a |
e-Terapèutica | n / a | n / a | n / a | n / a | n / a |
EastPharma Ltd RDA (Reg S) | n / a | n / a | n / a | n / a | n / a |
Grup de Sanitat Animal ECO | £0 | £0 | £0 | £11,439 | £31,438 |
Eden Research | £0 | £1,798,028 | £1,896,322 | £1,896,322 | £1,911,300 |
Ergomed | n / a | n / a | n / a | n / a | n / a |
Faron Pharmaceuticals Oy (DI) | n / a | n / a | n / a | n / a | n / a |
Futura Medical | £0 | £0 | £0 | £0 | - 37,983 lliures esterlines |
Biociències Genflow | £0 | £24,150 | £24,150 | £24,150 | £24,150 |
gènere | £0 | £0 | - 345,531 lliures esterlines | - 345,531 lliures esterlines | - 661,042 lliures esterlines |
GSK | £83,105 | £888,024 | £117,853,328 | £118,199,496 | £118,920,656 |
Gunsynd | £0 | £0 | £0 | £5,757 | £6,972 |
GW Pharmaceuticals | n / a | n / a | n / a | n / a | n / a |
Haleon | £0 | £0 | £0 | - 152,657 lliures esterlines | - 112,346 lliures esterlines |
Hemogenyx Pharmaceuticals | n / a | n / a | n / a | n / a | n / a |
Hikma Pharmaceuticals | £0 | - 49,986 lliures esterlines | - 49,986 lliures esterlines | - 49,986 lliures esterlines | - 25,734 lliures esterlines |
Grup Horizon Discovery | n / a | n / a | n / a | n / a | n / a |
HUTCHMED (Xina) Limitada | £0 | £0 | £0 | £0 | £0 |
Hvivo | n / a | n / a | n / a | n / a | n / a |
Immupharma | n / a | n / a | n / a | n / a | n / a |
Indivior | £0 | £0 | £980,027 | £1,179,756 | £1,345,082 |
Ixic | £0 | £0 | £0 | £25,039 | £230,039 |
LungLife AI, Inc (DI) | n / a | n / a | n / a | n / a | n / a |
Maxcyte Inc (DI / REG S) | n / a | n / a | n / a | n / a | n / a |
Grup Mereo Biopharma | n / a | n / a | n / a | n / a | n / a |
Motiu Bio | n / a | n / a | n / a | n / a | n / a |
N4 Pharma | n / a | n / a | n / a | n / a | n / a |
Nuformix | £0 | £0 | £0 | £28,000 | £28,000 |
Okyo Pharma Limited VAN | n / a | n / a | n / a | n / a | n / a |
Ondine Biomedical Inc. NPV (CDI) | £0 | £0 | £58,396 | £58,396 | £58,396 |
OptiBiotix Salut | £0 | £0 | £0 | £975,862 | £975,862 |
Ovoca Bio (CDI) | £0 | £0 | £0 | £0 | £0 |
Oxford Biomedica | n / a | n / a | n / a | n / a | n / a |
Oxford Cannabinoid Technologies Holdings | n / a | n / a | n / a | n / a | n / a |
Oxford Nanopore Technologies | £150 | £20,009 | £95,280 | £95,730 | - 3,849,712 lliures esterlines |
Pfizer Inc. | n / a | n / a | n / a | n / a | n / a |
OJSC Pharmstandard GDR (Reg S) | n / a | n / a | n / a | n / a | n / a |
Plethora Solutions Holdings | n / a | n / a | n / a | n / a | n / a |
Poolbeg Pharma | n / a | n / a | n / a | n / a | n / a |
Ciències del Proteoma | n / a | n / a | n / a | n / a | n / a |
Salut PureTech | £0 | £0 | £0 | £0 | - 719,950 lliures esterlines |
Quantum Pharma | n / a | n / a | n / a | n / a | n / a |
Redx Pharma | n / a | n / a | n / a | n / a | n / a |
Grup ReNeuron | n / a | n / a | n / a | n / a | n / a |
Sareum Holdings | £0 | £10,000 | £10,000 | £10,000 | £10,000 |
Scancell Holdings | n / a | n / a | n / a | n / a | n / a |
Escut Terapèutic | £0 | £0 | £21,275 | £21,275 | £21,275 |
Shire Plc | n / a | n / a | n / a | n / a | n / a |
Terapèutica del silenci | n / a | n / a | n / a | n / a | n / a |
Sinclair Pharma | n / a | n / a | n / a | n / a | n / a |
SkinBioTherapeutics | n / a | n / a | n / a | n / a | n / a |
Skyepharma | n / a | n / a | n / a | n / a | n / a |
Terapèutica Solvonis | £0 | £0 | £0 | £0 | £313,606 |
Font BioScience | n / a | n / a | n / a | n / a | n / a |
Summit Therapeutics | n / a | n / a | n / a | n / a | n / a |
Synairgen | n / a | n / a | n / a | n / a | n / a |
Taihua | n / a | n / a | n / a | n / a | n / a |
Theracryf | n / a | n / a | n / a | n / a | n / a |
Tiziana Ciències de la vida | n / a | n / a | n / a | n / a | n / a |
Valirx | n / a | n / a | n / a | n / a | n / a |
Grup Vectura | n / a | n / a | n / a | n / a | n / a |
Verici DX | n / a | n / a | n / a | n / a | n / a |
Vernalis plc | n / a | n / a | n / a | n / a | n / a |
Verona Pharma | n / a | n / a | n / a | n / a | n / a |
Verseon Corporation (DI / REG S) | n / a | n / a | n / a | n / a | n / a |
Verseon Corporation (Reg S Cat 3) | n / a | n / a | n / a | n / a | n / a |
Salut de Yourgene | n / a | n / a | n / a | n / a | n / a |